Knight Therapeutics launches Tavalisse in Brazil for chronic immune thrombocytopenia
Knight Therapeutics Inc announced the launch of Tavalisse in Brazil for the treatment of chronic immune thrombocytopenia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Knight Therapeutics Launches Tavalisse In Brazil
Knight Therapeutics Inc announced the launch of Tavalisse in Brazil for the treatment of chronic immune thrombocytopenia.